Cargando…
Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures
Despite the conventional view that a truly random V(D)J recombination process should generate a highly diverse immune repertoire, emerging reports suggest that there is a certain bias toward the generation of shared/public immune receptor chains. These studies were performed in viral diseases where...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476067/ https://www.ncbi.nlm.nih.gov/pubmed/34580764 http://dx.doi.org/10.1007/s00262-021-03047-7 |
_version_ | 1784575527262093312 |
---|---|
author | Teng, Yvonne H. F. Quah, Hong Sheng Suteja, Lisda Dias, João M. L. Mupo, Annalisa Bashford-Rogers, Rachael J. M. Vassiliou, George S. Chua, Melvin L. K. Tan, Daniel S. W. Lim, Darren W. T. Iyer, N. Gopalakrishna |
author_facet | Teng, Yvonne H. F. Quah, Hong Sheng Suteja, Lisda Dias, João M. L. Mupo, Annalisa Bashford-Rogers, Rachael J. M. Vassiliou, George S. Chua, Melvin L. K. Tan, Daniel S. W. Lim, Darren W. T. Iyer, N. Gopalakrishna |
author_sort | Teng, Yvonne H. F. |
collection | PubMed |
description | Despite the conventional view that a truly random V(D)J recombination process should generate a highly diverse immune repertoire, emerging reports suggest that there is a certain bias toward the generation of shared/public immune receptor chains. These studies were performed in viral diseases where public T cell receptors (TCR) appear to confer better protective responses. Selective pressures generating common TCR clonotypes are currently not well understood, but it is believed that they confer a growth advantage. As very little is known about public TCR clonotypes in cancer, here we set out to determine the extent of shared TCR clonotypes in the intra-tumor microenvironments of virus- and non-virus-driven head and neck cancers using TCR sequencing. We report that tumor-infiltrating T cell clonotypes were indeed shared across individuals with the same cancer type, where the majority of shared sequences were specific to the cancer type (i.e., viral versus non-viral). These shared clonotypes were not particularly enriched in EBV-associated nasopharynx cancer but, in both cancers, exhibited distinct characteristics, namely shorter CDR3 lengths, restricted V- and J-gene usages, and also demonstrated convergent V(D)J recombination. Many of these shared TCRs were expressed in patients with a shared HLA background. Pattern recognition of CDR3 amino acid sequences revealed strong convergence to specific pattern motifs, and these motifs were uniquely found to each cancer type. This suggests that they may be enriched for specificity to common antigens found in the tumor microenvironment of different cancers. The identification of shared TCRs in infiltrating tumor T cells not only adds to our understanding of the tumor-adaptive immune recognition but could also serve as disease-specific biomarkers and guide the development of future immunotherapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00262-021-03047-7. |
format | Online Article Text |
id | pubmed-8476067 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-84760672021-09-28 Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures Teng, Yvonne H. F. Quah, Hong Sheng Suteja, Lisda Dias, João M. L. Mupo, Annalisa Bashford-Rogers, Rachael J. M. Vassiliou, George S. Chua, Melvin L. K. Tan, Daniel S. W. Lim, Darren W. T. Iyer, N. Gopalakrishna Cancer Immunol Immunother Research Report Despite the conventional view that a truly random V(D)J recombination process should generate a highly diverse immune repertoire, emerging reports suggest that there is a certain bias toward the generation of shared/public immune receptor chains. These studies were performed in viral diseases where public T cell receptors (TCR) appear to confer better protective responses. Selective pressures generating common TCR clonotypes are currently not well understood, but it is believed that they confer a growth advantage. As very little is known about public TCR clonotypes in cancer, here we set out to determine the extent of shared TCR clonotypes in the intra-tumor microenvironments of virus- and non-virus-driven head and neck cancers using TCR sequencing. We report that tumor-infiltrating T cell clonotypes were indeed shared across individuals with the same cancer type, where the majority of shared sequences were specific to the cancer type (i.e., viral versus non-viral). These shared clonotypes were not particularly enriched in EBV-associated nasopharynx cancer but, in both cancers, exhibited distinct characteristics, namely shorter CDR3 lengths, restricted V- and J-gene usages, and also demonstrated convergent V(D)J recombination. Many of these shared TCRs were expressed in patients with a shared HLA background. Pattern recognition of CDR3 amino acid sequences revealed strong convergence to specific pattern motifs, and these motifs were uniquely found to each cancer type. This suggests that they may be enriched for specificity to common antigens found in the tumor microenvironment of different cancers. The identification of shared TCRs in infiltrating tumor T cells not only adds to our understanding of the tumor-adaptive immune recognition but could also serve as disease-specific biomarkers and guide the development of future immunotherapies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00262-021-03047-7. Springer Berlin Heidelberg 2021-09-27 2022 /pmc/articles/PMC8476067/ /pubmed/34580764 http://dx.doi.org/10.1007/s00262-021-03047-7 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021, corrected publication 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Report Teng, Yvonne H. F. Quah, Hong Sheng Suteja, Lisda Dias, João M. L. Mupo, Annalisa Bashford-Rogers, Rachael J. M. Vassiliou, George S. Chua, Melvin L. K. Tan, Daniel S. W. Lim, Darren W. T. Iyer, N. Gopalakrishna Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
title | Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
title_full | Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
title_fullStr | Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
title_full_unstemmed | Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
title_short | Analysis of T cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
title_sort | analysis of t cell receptor clonotypes in tumor microenvironment identifies shared cancer-type-specific signatures |
topic | Research Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476067/ https://www.ncbi.nlm.nih.gov/pubmed/34580764 http://dx.doi.org/10.1007/s00262-021-03047-7 |
work_keys_str_mv | AT tengyvonnehf analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT quahhongsheng analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT sutejalisda analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT diasjoaoml analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT mupoannalisa analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT bashfordrogersrachaeljm analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT vassiliougeorges analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT chuamelvinlk analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT tandanielsw analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT limdarrenwt analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures AT iyerngopalakrishna analysisoftcellreceptorclonotypesintumormicroenvironmentidentifiessharedcancertypespecificsignatures |